Response to Prieto et al, “RE: External validation of the Melanoma Institute Australia sentinel lymph metastasis risk prediction tool using the National Cancer Database” - 30/05/24
Doi : 10.1016/j.jaad.2024.04.074
S. Caleb Freeman, MD a, ⁎ 
, Elena Paz Munoz, BS a, Emile Latour, MS b, Jeong Youn Lim, PhD b, Wesley Yu, MD a
, Elena Paz Munoz, BS a, Emile Latour, MS b, Jeong Youn Lim, PhD b, Wesley Yu, MD a a Department of Dermatology, Oregon Health & Science University, Portland, Oregon
b Biostatistics Shared Resource, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon
∗Correspondence to: S. Caleb Freeman, MD, Department of Dermatology, Oregon Health & Science University, 3303 S Bond Ave, Building 1, 16th Floor, Portland, OR 97239Department of DermatologyOregon Health & Science University3303 S Bond AveBuilding 116th FloorPortlandOR97239
In corso di stampa. Prove corrette dall'autore.
Disponibile online dal Thursday 30 May 2024
This article has been published in an issue click here to access
This article has been published in an issue click here to access
Key words : melanoma, model, nomogram, oncology, risk assessment, sentinel lymph node, surgery
Il testo completo di questo articolo è disponibile in PDF.
| Funding sources: Biostatistics support was provided by the Biostatistics Shared Resource, Knight Cancer Institute [NCI P30CA069533] (EL, JYL). |
|
| Patient consent: Not applicable. |
|
| IRB approval status: Not applicable. |
© 2024
American Academy of Dermatology, Inc.. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?